DOUGLAS MILOSAVLJEVIC: Open Payments
NPI 1831173822 · FRANKLIN, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 29 payments from 7 companies in 2025. Trend: 2023 $777 · 2024 $602 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 16 | $253 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $78 |
| Lundbeck LLC | 3 | $59 |
| ABBVIE INC. | 2 | $56 |
| PFIZER INC. | 2 | $48 |
| Valinor Pharma, LLC | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: XTAMPZA, Belbuca, JOURNAVX, VYEPTI, NURTEC ODT, QULIPTA, MOVANTIK, UBRELVY.
Industry payments across WI — which companies pay providers there.
